Inventor · disambiguated record
David Bates
Also filed as: BATES DAVID · BATES DAVID O · BATES DAVID OWEN
11 granted patents·3 pending applications·11 citations·filing 2002–2017
82Inventor score
Top patents by PatentIndex Score
14 records- 0176US8592563B2Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (VEGF)BATES DAVID O·Filed 2008·Granted Nov 26, 2013·9 cites·4 claims
- 0269US9695160B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2015·Granted Jul 4, 2017·1 cites·20 claims
- 0363US10301264B2Compounds useful for treating ocular neovasculanUNIV NOTTINGHAM·Filed 2013·Granted May 28, 2019·1 cites·9 claims
- 0459US8933211B2Growth factor isoformUNIV BRISTOL·Filed 2013·Granted Jan 13, 2015·0 cites·15 claims
- 0557US9932330B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2017·Granted Apr 3, 2018·0 cites·20 claims
- 0656US9796707B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2017·Granted Oct 24, 2017·0 cites·20 claims
- 0750US8394930B2Growth factor isoformBATES DAVID O·Filed 2010·Granted Mar 12, 2013·0 cites·1 claims
- 0848US2011039772A1Novel uses of vegfxxxbBATES DAVID·Filed 2009·Application pending·0 cites
- 0946US7820178B2VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agentsUNIV BRISOL·Filed 2002·Granted Oct 26, 2010·0 cites·8 claims
- 1046US2013287803A1Novel uses of vegfxxxbUNIV BRISTOL·Filed 2013·Application pending·0 cites
- 1143US9447418B2Pro- and anti-angiogenic treatmentsBATES DAVID·Filed 2008·Granted Sep 20, 2016·0 cites·5 claims
- 1241US10696661B2CompoundsEXONATE LTD·Filed 2016·Granted Jun 30, 2020·0 cites·21 claims
- 1332US8530150B2Detection of risk of pre-eclampsiaBATES DAVID OWEN·Filed 2010·Granted Sep 10, 2013·0 cites·13 claims
- 1431US2012010138A1Novel uses of vegfxxxbBATES DAVID OWEN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Bates files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →